204 related articles for article (PubMed ID: 36200983)
1. Mice with R2509C-RYR1 mutation exhibit dysfunctional Ca2+ dynamics in primary skeletal myocytes.
Tsuboi Y; Oyama K; Kobirumaki-Shimozawa F; Murayama T; Kurebayashi N; Tachibana T; Manome Y; Kikuchi E; Noguchi S; Inoue T; Inoue YU; Nishino I; Mori S; Ishida R; Kagechika H; Suzuki M; Fukuda N; Yamazawa T
J Gen Physiol; 2022 Nov; 154(11):. PubMed ID: 36200983
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Chlorantraniliprole and Flubendiamide Activity Toward Wild-Type and Malignant Hyperthermia-Susceptible Ryanodine Receptors and Heat Stress Intolerance.
Truong KM; Pessah IN
Toxicol Sci; 2019 Feb; 167(2):509-523. PubMed ID: 30329129
[TBL] [Abstract][Full Text] [Related]
3. A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR.
Estève E; Eltit JM; Bannister RA; Liu K; Pessah IN; Beam KG; Allen PD; López JR
J Gen Physiol; 2010 Jun; 135(6):619-28. PubMed ID: 20479110
[TBL] [Abstract][Full Text] [Related]
4. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
Yang T; Esteve E; Pessah IN; Molinski TF; Allen PD; López JR
Am J Physiol Cell Physiol; 2007 May; 292(5):C1591-8. PubMed ID: 17182726
[TBL] [Abstract][Full Text] [Related]
5. A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice.
Andronache Z; Hamilton SL; Dirksen RT; Melzer W
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4531-6. PubMed ID: 19246389
[TBL] [Abstract][Full Text] [Related]
6. A malignant hyperthermia-inducing mutation in RYR1 (R163C): consequent alterations in the functional properties of DHPR channels.
Bannister RA; Estève E; Eltit JM; Pessah IN; Allen PD; López JR; Beam KG
J Gen Physiol; 2010 Jun; 135(6):629-40. PubMed ID: 20479108
[TBL] [Abstract][Full Text] [Related]
7. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
Loy RE; Orynbayev M; Xu L; Andronache Z; Apostol S; Zvaritch E; MacLennan DH; Meissner G; Melzer W; Dirksen RT
J Gen Physiol; 2011 Jan; 137(1):43-57. PubMed ID: 21149547
[TBL] [Abstract][Full Text] [Related]
8. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.
Yang T; Ta TA; Pessah IN; Allen PD
J Biol Chem; 2003 Jul; 278(28):25722-30. PubMed ID: 12732639
[TBL] [Abstract][Full Text] [Related]
9. Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle.
Barrientos GC; Feng W; Truong K; Matthaei KI; Yang T; Allen PD; Lopez JR; Pessah IN
J Biol Chem; 2012 Jan; 287(4):2863-76. PubMed ID: 22139840
[TBL] [Abstract][Full Text] [Related]
10. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
Ta TA; Pessah IN
Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
[TBL] [Abstract][Full Text] [Related]
11. Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1.
Lopez JR; Kaura V; Diggle CP; Hopkins PM; Allen PD
Br J Anaesth; 2018 Oct; 121(4):953-961. PubMed ID: 30236258
[TBL] [Abstract][Full Text] [Related]
12. Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor.
Eltit JM; Bannister RA; Moua O; Altamirano F; Hopkins PM; Pessah IN; Molinski TF; López JR; Beam KG; Allen PD
Proc Natl Acad Sci U S A; 2012 May; 109(20):7923-8. PubMed ID: 22547813
[TBL] [Abstract][Full Text] [Related]
13. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.
Chelu MG; Goonasekera SA; Durham WJ; Tang W; Lueck JD; Riehl J; Pessah IN; Zhang P; Bhattacharjee MB; Dirksen RT; Hamilton SL
FASEB J; 2006 Feb; 20(2):329-30. PubMed ID: 16284304
[TBL] [Abstract][Full Text] [Related]
14. Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice.
Feng W; Barrientos GC; Cherednichenko G; Yang T; Padilla IT; Truong K; Allen PD; Lopez JR; Pessah IN
Mol Pharmacol; 2011 Mar; 79(3):420-31. PubMed ID: 21156754
[TBL] [Abstract][Full Text] [Related]
15. Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.
Dirksen RT; Avila G
Biophys J; 2004 Nov; 87(5):3193-204. PubMed ID: 15347586
[TBL] [Abstract][Full Text] [Related]
16. Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP.
Diaz-Sylvester PL; Porta M; Copello JA
Am J Physiol Cell Physiol; 2008 Apr; 294(4):C1103-12. PubMed ID: 18305228
[TBL] [Abstract][Full Text] [Related]
17. Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations.
Yang T; Allen PD; Pessah IN; Lopez JR
J Biol Chem; 2007 Dec; 282(52):37471-8. PubMed ID: 17942409
[TBL] [Abstract][Full Text] [Related]
18. Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage.
Yuen B; Boncompagni S; Feng W; Yang T; Lopez JR; Matthaei KI; Goth SR; Protasi F; Franzini-Armstrong C; Allen PD; Pessah IN
FASEB J; 2012 Mar; 26(3):1311-22. PubMed ID: 22131268
[TBL] [Abstract][Full Text] [Related]
19. Insights into channel modulation mechanism of RYR1 mutants using Ca2+ imaging and molecular dynamics.
Yamazawa T; Ogawa H; Murayama T; Yamaguchi M; Oyamada H; Suzuki J; Kurebayashi N; Kanemaru K; Oguchi K; Sakurai T; Iino M
J Gen Physiol; 2020 Jan; 152(1):. PubMed ID: 31841587
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.
Yang T; Riehl J; Esteve E; Matthaei KI; Goth S; Allen PD; Pessah IN; Lopez JR
Anesthesiology; 2006 Dec; 105(6):1164-75. PubMed ID: 17122579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
